NEW YORK (GenomeWeb News) – PositiveID said today that its subsidiary MicroFluidic Systems is partnering with the University of Nevada to complete development of PositiveID's biodosimetry cartridge for measuring radiation levels.
By a GenomeWeb staff reporter
The University of Nevada’s School of Medicine will use a March of Dimes grant to study gene expression in a variant that could be used to develop a screening test for preterm birth.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.